Jamie L. Sanz

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.

Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC.

Journal: Bone marrow transplantation

Published: November 26, 2024

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

Journal: Bone marrow transplantation

Published: May 20, 2024

Biomineralization potential and biological properties of a new tantalum oxide (Ta2O5)-containing calcium silicate cement.

Biomineralization potential and biological properties of a new tantalum oxide (Ta2O5)-containing calcium silicate cement.

Journal: Clinical oral investigations

Published: April 22, 2021

Cytocompatibility and bioactive properties of the new dual-curing resin-modified calcium silicate-based material for vital pulp therapy.

Cytocompatibility and bioactive properties of the new dual-curing resin-modified calcium silicate-based material for vital pulp therapy.

Journal: Clinical oral investigations

Published: October 31, 2020

Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Outcome of T-cell-replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Journal: Cancer

Published: October 15, 2020

Microstructural composition, ion release, and bioactive potential of new premixed calcium silicate-based endodontic sealers indicated for warm vertical compaction technique.

Microstructural composition, ion release, and bioactive potential of new premixed calcium silicate-based endodontic sealers indicated for warm vertical compaction technique.

Journal: Clinical oral investigations

Published: May 18, 2020

Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Journal: Bone marrow transplantation

Published: March 08, 2020

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients.

Journal: Bone marrow transplantation

Published: October 10, 2019

Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission.

Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission.

Journal: Journal of internal medicine

Published: December 19, 2018

Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.

Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.

Journal: Journal of internal medicine

Published: October 05, 2017

One or two umbilical cord blood cell units? Caveat emptor.

One or two umbilical cord blood cell units? Caveat emptor.

Journal: Bone marrow transplantation

Published: July 20, 2016

The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial).

The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial).

Journal: Bone marrow transplantation

Published: May 24, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026